These injections may be used to treat vitreous hemorrhage caused by some conditions like diabetic retinopathy. If your doctor doesn’t think your blood will reabsorb by itself without causing ...

Various systemic conditions may predispose the patient to vitreous hemorrhage (e.g., diabetes mellitus, sickle cell disease, vasculitis) or retinal breaks (e.g., Stickler syndrome). Examination of ...

Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 ...

A recent study published in the journal JAMA Ophthalmology found that empagliflozin was associated with a reduced risk of the ...

"To our knowledge, this is the first study to evaluate diabetic retinopathy progression using data generated from clinical ...